455
Participants
Start Date
September 30, 2008
Primary Completion Date
February 28, 2011
Study Completion Date
July 31, 2011
XIENCE V®/ XIENCE PRIME™
Coronary artery placement of a XIENCE V®/ XIENCE PRIME™ Everolimus Eluting Stent System
CYPHER SELECT
XIENCE V® / XIENCE PRIME™ to CYPHER SELECT in female patients with de novo coronary artery lesions
Latvian Center of Cardiology, P. Stradina University Hospital, Riga
Allgemeines Krankenhaus der Stadt Wien - Univ.Klinik f. Innere Medizin II, Vienna
AMC, Amsterdam
Hosital Italiano de Buenos Aires - Cardiologia, Buenos Aires
Instituto Cardiovascular de Buenos Aires-ICBA, Buenos Aires
Hospital General de Alicante, Alicante
Inselspital Bern, Kardiologie, Bern
St. Antonius Ziekenhuis, Nieuwegein
Haukeland university hospital, Bergen
Cardiocentro Ticino, Lugano
Heilig Hart Ziekenhuis Roeselare, Roeselare
Istituto Clinico Humanitas, Rozzano
Centro Cardiologico Monzino, Milan
Clinico S.Ambrogio, GRUPPO OSPEDALIERO SAN DONATO, Milan
Segebergerkliniken, Bad Segeberg
Kardiologische Klinik Herz- und Diabeteszentrum, Bad Oeynhausen
Azienda Policlinico di Modena U.O. Cardiologia, Ospedale di Modena, Modena
Ospedale Cisanello, Pisa
Institut Hospitalier Jacques Cartier Service d'Angiographie, Inst Cardiovasculaire Paris-Sud, Massy
Instituto de Cardiologia Dante Pazzanese Unidadae II Recepcao de Angioplastia, São Paulo
Rigshospitalet, Copenhagen
Semmelweis University, Department of Cardiovascular Surgery, Budapest
Technische Universität Dresden, Medizinische Klinik II - Kardiologie, Dresden
Institute of Cardiology, Warsaw
Hospital Universitari Germans Trias i Pujol, Barcelona
Lead Sponsor
Abbott Medical Devices
INDUSTRY